BCM
ELV icon

BlueCrest Capital Management’s Elevance Health ELV Stock Holding History

BlueCrest Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,700
Closed -$2.44M – 155
2024
Q1 		$2.44M Buy
+4,700
New +$2.34M 0.12% 107

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlueCrest Capital Management's ELV Position: Q1 2024 in Review

BlueCrest Capital Management sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 1,574 shares — an estimated $783K sold.

BlueCrest Capital Management first reported a position in ELV in Q4 2014 and held it in 9 quarters. The position peaked at $4.5M in Q4 2017. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

  • BlueCrest Capital Management reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
  • BlueCrest Capital Management sold 1,574 Elevance Health shares in Q1 2024, an estimated $783K.
  • BlueCrest Capital Management first reported a position in Elevance Health in Q4 2014 and held it in 9 quarters.
  • BlueCrest Capital Management's Elevance Health position peaked at $4.5M in Q4 2017.
  • 1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on BlueCrest Capital Management's 13F filing for Q1 2024, filed 15 May 2024.